Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
11,16 SEK | +5,28% | -15,33% | +231,16% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 377 mln. 34,44 mln. 32,21 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -37 mln. -3,38 mln. -3,16 mln. | Nettowinst (verlies) 2025 * | -102 mln. -9,32 mln. -8,72 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 18,35 mln. 1,68 mln. 1,57 mln. | Nettoliquiditeiten 2025 * | 57 mln. 5,21 mln. 4,87 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-8,68
x | K/w-verhouding 2025 * |
-4,51
x | Werknemers | 13 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 74,72% |
Recentste transcriptie over Ascelia Pharma AB
1 dag | +5,28% | ||
1 week | -15,33% | ||
Lopende maand | +21,17% | ||
1 maand | +14,58% | ||
3 maanden | +28,42% | ||
6 maanden | +273,24% | ||
Lopend jaar | +231,16% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 49 | 01-01-14 | |
Director of Finance/CFO | 52 | 01-01-20 | |
Chief Tech/Sci/R&D Officer | 40 | 01-01-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 69 | 01-06-17 | |
Niels Mengel
BRD | Director/Board Member | 76 | 01-01-00 |
Director/Board Member | 59 | 01-01-17 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 11,16 | +5,28% | 118 115 |
25-04-24 | 10,6 | +9,84% | 279 835 |
24-04-24 | 9,65 | -23,05% | 458 993 |
23-04-24 | 12,54 | -1,72% | 186 740 |
22-04-24 | 12,76 | -3,19% | 144 180 |
uitgestelde koers Nasdaq Stockholm, 26 april 2024 om 17:29 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+231,16% | 34,36 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |